BGB-3111-112
Completed
The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
BeOne Study ID 
BGB-3111-112
ClinicalTrials.gov ID
Study Overview
Sex:
Male
Age: 18 Years / 65 Years
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex:
Male
Age: 18 Years / 65 Years